00068-7/asset/fd53a887-7fc5-47e3-8cb1-2f290875bdb9/main.assets/gr3_lrg.jpg)
novo nordisk semaglutide nash 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial Therapeutic Potential of Semaglutide, a
Description
A: It is commonly used for diabetes and weight management
J Pers Med [Internet]
Differences between randomized clinical trial patients and real-world initiators of the glucagon-like peptide 1 receptor agonist liraglutide
Wauters L, Vanuytsel T
Taking 80120 mg after meals or when bloating begins can provide modest relief within 30 minutes
Long-acting somatostatin analogs, such as pasireotide (half-life 11 h), may be more promising and lead to a better adherence of the patients [51]
